Page 3 - Celonic Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

April 7, 2021 | 5:45 pm Font Size REUTERS BERLIN — Global supply chains for making COVID-19 vaccines have been disrupted by US restrictions, creating headaches for companies seeking to build production in Europe, according to one of the founders of Germany’s Curevac. Florian von der Muelbe said in a newspaper interview that he was hopeful Curevac’s vaccine candidate would win emergency European approval this quarter and confirmed a forecast that it would produce 300 million doses this year. He added, however, that vaccine makers seeking to build production in Europe we...

Production of CureVac’s CVnCoV vaccine will take place in Germany, with over 50 million doses expected to be produced in 2021.

Search jobs 26-Feb-2021 Celonic to Boost its Cell & Gene Therapy Production with Facility in the Upcoming Life Science Park Rheintal in Stein, Switzerland Celonic to Boost its Cell & Gene Therapy Production with Facility in the Upcoming Life Science Park Rheintal in Stein, Switzerland BASEL, Switzerland, February 25, 2021 / B3C newswire / --Celonic Group, a leading global contract development and manufacturing organization (CDMO), specialized in development and production of Advanced Therapy Medicinal Products (ATMP) and bio-therapeutics, today an...

(0) DGAP-News: Celonic AG / Key word(s): Expansion Celonic AG: Celonic to Boost its Cell & Gene Therapy Production with Facility in the upcoming Life Science Park Rheintal in Stein, Switzerland 25.02.2021 / 16:00 The issuer is solely responsible for the content of this announcement. Celonic to Boost its Cell & Gene Therapy Production with Facility in the upcoming Life Science Park Rheintal in Stein, Switzerland Basel, Switzerland, 25 th February 2021 - Celonic Group, a leading global contract development and manufacturing organization (CDMO), specialized in development and production of A...